{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:39:34Z","timestamp":1761896374366},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejca.2016.08.011","type":"journal-article","created":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T20:56:50Z","timestamp":1474750610000},"page":"183-190","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America"],"prefix":"10.1016","volume":"67","author":[{"given":"Maria A.","family":"Karalexi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Baka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Ryzhov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zborovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadya","family":"Dimitrova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snezana","family":"Zivkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan","family":"Eser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Sekerija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Demetriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenic","family":"Agius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margareta","family":"Florea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Coza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Polychronopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eftichia","family":"Stiakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Moschovi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Hatzipantelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kourti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stelios","family":"Graphakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria S.","family":"Pombo-de-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Olov","family":"Adami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni Th.","family":"Petridou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2016.08.011_bib1","series-title":"Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975\u20131995","year":"1999"},{"issue":"35","key":"10.1016\/j.ejca.2016.08.011_bib2","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.08.011_bib3","first-page":"357027","article-title":"Imatinib: a breakthrough of targeted therapy in cancer","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Chemother Res Pract"},{"issue":"10","key":"10.1016\/j.ejca.2016.08.011_bib4","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/pbc.25120","article-title":"International patterns of childhood chronic myeloid leukemia: comparisons between the United States and resource-restricted nations","volume":"61","author":"Sadak","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2016.08.011_bib5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ejca.2015.02.018","article-title":"EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: improving performance by research programming for public health and clinical evaluation","volume":"51","author":"Coebergh","year":"2015","journal-title":"Eur J Cancer"},{"issue":"17","key":"10.1016\/j.ejca.2016.08.011_bib6","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.ejca.2015.08.018","article-title":"Childhood central nervous system tumour mortality and survival in Southern and Eastern Europe (1983\u20132014): gaps persist across 14 cancer registries","volume":"51","author":"Karalexi","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2016.08.011_bib7","series-title":"Standards and guidelines for cancer registration in Europe IARC technical publication No. 40","first-page":"69","author":"Tyczynski","year":"2003"},{"key":"10.1016\/j.ejca.2016.08.011_bib8","unstructured":"National Cancer Institute. Surveillance E, and End Results Program. In Edition."},{"key":"10.1016\/j.ejca.2016.08.011_bib9","series-title":"International classification of diseases for oncology: ICD-O","author":"Fritz","year":"2000"},{"issue":"7","key":"10.1016\/j.ejca.2016.08.011_bib10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cncr.20910","article-title":"International classification of childhood cancer, third edition","volume":"103","author":"Steliarova-Foucher","year":"2005","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2016.08.011_bib11","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/j.ejca.2016.08.011_bib12","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1007\/s00277-015-2319-x","article-title":"Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU","volume":"94","author":"Conti","year":"2015","journal-title":"Ann Hematol"},{"issue":"22","key":"10.1016\/j.ejca.2016.08.011_bib13","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1182\/blood-2013-03-490003","article-title":"The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts","volume":"121","author":"Experts in Chronic Myeloid L","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejca.2016.08.011_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/bjh.13453","article-title":"Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience","volume":"170","author":"Giona","year":"2015","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.ejca.2016.08.011_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2015-06-648667","article-title":"Pediatric chronic myeloid leukemia is a unique disease that requires a different approach","volume":"127","author":"Hijiya","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejca.2016.08.011_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pcl.2014.09.008","article-title":"Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions","volume":"62","author":"Hijiya","year":"2015","journal-title":"Pediatr Clin North Am"},{"issue":"6","key":"10.1016\/j.ejca.2016.08.011_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajh.22019","article-title":"Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia","volume":"86","author":"Ganesan","year":"2011","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.ejca.2016.08.011_bib18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2011-10-380774","article-title":"How I treat childhood CML","volume":"119","author":"Andolina","year":"2012","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.ejca.2016.08.011_bib19","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1200\/JCO.2010.32.7114","article-title":"Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial","volume":"29","author":"Millot","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2016.08.011_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/08880018.2012.691946","article-title":"Chronic myeloid leukemia (CML) in children: classical and newer therapeutic approaches","volume":"29","author":"Ampatzidou","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2016.08.011_bib21","first-page":"1","article-title":"Possible implication of IKAROS gene deletion and BCR-ABL1 variants in progression of chronic myeloid leukemia to lymphoid blast crisis in childhood: a single-institution experience","author":"Moschovi","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.ejca.2016.08.011_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pbc.23007","article-title":"Successful bone marrow transplantation in a pediatric patient with chronic myeloid leukemia from a HLA-identical sibling selected by preimplantation HLA testing","volume":"57","author":"Goussetis","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2016.08.011_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/bjh.12977","article-title":"Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years","volume":"167","author":"de la Fuente","year":"2014","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.ejca.2016.08.011_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/pbc.23389","article-title":"Imatinib has adverse effect on growth in children with chronic myeloid leukemia","volume":"59","author":"Bansal","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2016.08.011_bib25","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1182\/blood-2007-10-114900","article-title":"The effects of imatinib on pregnancy outcome","volume":"111","author":"Pye","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ejca.2016.08.011_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2796.2006.01677.x","article-title":"Interpreting trends in cancer patient survival","volume":"260","author":"Dickman","year":"2006","journal-title":"J Intern Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491632384X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491632384X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T04:01:59Z","timestamp":1536379319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491632384X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":26,"alternative-id":["S095980491632384X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2016.08.011","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2016.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}